The Latest Breaking News from FDA

Joseph Cassara decided to head back to the emergency room when the pain made it unbearable to swallow.

Wall Street Journal

As monkeypox cases continue to increase among high-risk people, federal officials on Tuesday announced they will stretch limited vaccine supplies by giving just one-fifth the current dosage.

The FDA has issued emergency authorisation for a dosage technique that would allow more shots of vaccine per vial.

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder (MDD). Relmada shares traded in a range of $26.02 to $27.96 on a day volume of 173.79 thousand shares, closed regular trading…

The Biden administration is allowing the shot to be given between layers of skin — a method that only requires a fifth of the full dose — in order to increase vaccinations and slow the outbreak.

U.S. health officials are endorsing a new monkeypox vaccination strategy designed to stretch limited supplies by allowing health professionals to vaccinate up to five people — instead of one — with each vial

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 100 points on Tuesday.

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.